Sanitary and Phytosanitary
Information Management System
Specific Trade Concerns
Other SPS Documents
Enquiry Points/Notification Authorities
Compare notifications between two time periods
Definitions of groups
STC Number - 152
Restrictions on melons
United States of America
First date raised:
, paras. 179-180
Dates subsequently raised:
Number of times subsequently raised:
0807 Melons (including watermelons) and papaws (papayas), fresh.
Primary subject keyword:
Control, Inspection and Approval Procedures; Food safety; Human health
Date reported as resolved:
Extracts from SPS Committee meeting summary reports
Mexico indicated that on 28 October 2002, the US Food and Drug Administration (FDA) imposed an emergency import ban on cantaloupe melons imported from Mexico. Mexico considered this measure as being disproportionate and not based on scientific evidence of any health risk (G/SPS/GEN/366). Mexico requested the United States to suspend the import ban on cantaloupe melons and to comply with its obligations under the SPS Agreement.
The United States noted that FDA sampling of imported produce found that samples of cantaloupe melons from most growing regions in Mexico tested positive for salmonella. The samples had been collected both in the fall/winter and spring/summer seasons, and it appeared that unsanitary conditions in the growing and packing of cantaloupe melons had resulted in four salmonella outbreaks. The import alert recommended officials to detain cantaloupe melons from Mexico at all US ports without physical examination. The October import alert expanded prior import alerts that had targeted specific imports and growers whose products had been linked to outbreaks or had tested positive for salmonella. On 28 October 2002, the United States had announced that they would continue to work with Mexico on a food safety programme for production, packing and shipping of fresh cantaloupe melons. The Mexican Government had proposed a certification programme based on good agricultural practices and good manufacturing practices that would allow the FDA to identify firms that had adopted and implemented such a programme. This certification programme was still under development and the United States looked forward to its early implementation.
© World Trade Organization 2020
ver 188.8.131.52733 (12/06/2019 03:26 PM)